These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 30200851)

  • 1. Ebola: Lessons on Vaccine Development.
    Feldmann H; Feldmann F; Marzi A
    Annu Rev Microbiol; 2018 Sep; 72():423-446. PubMed ID: 30200851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can Ebola Virus Vaccines Have Universal Immune Correlates of protection?
    Meyer M; Malherbe DC; Bukreyev A
    Trends Microbiol; 2019 Jan; 27(1):8-16. PubMed ID: 30201511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ebola vaccine trials: progress in vaccine safety and immunogenicity.
    Matz KM; Marzi A; Feldmann H
    Expert Rev Vaccines; 2019 Dec; 18(12):1229-1242. PubMed ID: 31779496
    [No Abstract]   [Full Text] [Related]  

  • 4. Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases.
    Tully CM; Lambe T; Gilbert SC; Hill AV
    Lancet Infect Dis; 2015 Mar; 15(3):356-9. PubMed ID: 25595637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ebola virus vaccines - reality or fiction?
    Mire CE; Geisbert TW; Feldmann H; Marzi A
    Expert Rev Vaccines; 2016 Nov; 15(11):1421-1430. PubMed ID: 27078187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons learned from Ebola Vaccine R&D during a public health emergency.
    Kieny MP
    Hum Vaccin Immunother; 2018; 14(9):2114-2115. PubMed ID: 29452047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ebola Virus: Pathogenesis and Countermeasure Development.
    Furuyama W; Marzi A
    Annu Rev Virol; 2019 Sep; 6(1):435-458. PubMed ID: 31567063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 9. The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials.
    Suder E; Furuyama W; Feldmann H; Marzi A; de Wit E
    Hum Vaccin Immunother; 2018; 14(9):2107-2113. PubMed ID: 29757706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ebola vaccines - Where are we?
    Watle SV; Norheim G; Røttingen JA
    Hum Vaccin Immunother; 2016 Oct; 12(10):2700-2703. PubMed ID: 27548643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain.
    Marzi A; Robertson SJ; Haddock E; Feldmann F; Hanley PW; Scott DP; Strong JE; Kobinger G; Best SM; Feldmann H
    Science; 2015 Aug; 349(6249):739-42. PubMed ID: 26249231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ebola virus vaccines: an overview of current approaches.
    Marzi A; Feldmann H
    Expert Rev Vaccines; 2014 Apr; 13(4):521-31. PubMed ID: 24575870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines against 'the other' Ebolavirus species.
    Kozak RA; Kobinger GP
    Expert Rev Vaccines; 2016 Sep; 15(9):1093-100. PubMed ID: 27010528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebola vaccines in clinical trial: The promising candidates.
    Wang Y; Li J; Hu Y; Liang Q; Wei M; Zhu F
    Hum Vaccin Immunother; 2017 Jan; 13(1):153-168. PubMed ID: 27764560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Against the clock towards new Ebola virus therapies.
    Martínez-Romero C; García-Sastre A
    Virus Res; 2015 Nov; 209():4-10. PubMed ID: 26057711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.
    Dhama K; Karthik K; Khandia R; Chakraborty S; Munjal A; Latheef SK; Kumar D; Ramakrishnan MA; Malik YS; Singh R; Malik SVS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():1803. PubMed ID: 30147687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the development of vaccines for Ebola virus disease.
    Ohimain EI
    Virus Res; 2016 Jan; 211():174-85. PubMed ID: 26596227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Ebola vaccine trials: insights from simulation.
    Pulliam JRC; Bellan SE; Gambhir M; Meyers LA; Dushoff J
    Lancet Infect Dis; 2015 Oct; 15(10):1134. PubMed ID: 26461945
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of Vesicular Stomatitis Virus-Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona.
    Marzi A; Hanley PW; Haddock E; Martellaro C; Kobinger G; Feldmann H
    J Infect Dis; 2016 Oct; 214(suppl 3):S360-S366. PubMed ID: 27496978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Closer than ever to an Ebola virus vaccine.
    Banadyga L; Marzi A
    Expert Rev Vaccines; 2017 May; 16(5):401-402. PubMed ID: 28322076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.